XOMA Royalty Corporation
NASDAQ: XOMA · HEALTHCARE · BIOTECHNOLOGY
Updated 2026-06-05
XOMA Royalty Corporation (XOMA) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $29.50M | $-51.84M | 100.00% | -137.92% | -175.74% |
| 2007 | $84.25M | $-12.33M | 100.00% | -3.02% | -14.63% |
| 2008 | $67.99M | $-45.24M | 100.00% | -56.97% | -66.55% |
| 2009 | $98.43M | $550000.00 | 100.00% | 13.17% | 0.56% |
| 2010 | $33.64M | $-68.76M | 100.00% | -199.47% | -204.38% |
| 2011 | $58.20M | $-32.74M | 100.00% | -58.35% | -56.26% |
| 2012 | $33.78M | $-71.06M | 99.58% | -167.62% | -210.36% |
| 2013 | $35.45M | $-124.06M | 22.82% | -164.18% | -349.94% |
| 2014 | $18.87M | $-38.30M | -56.19% | -433.75% | -203.02% |
| 2015 | $55.45M | $-20.61M | 62.67% | -71.64% | -37.16% |
| 2016 | $5.56M | $-53.53M | 74.84% | -1,106.36% | -962.08% |
| 2017 | $52.69M | $14.60M | 85.05% | 32.32% | 27.70% |
| 2018 | $5.30M | $-13.34M | 68.26% | -318.12% | -251.80% |
| 2019 | $18.37M | $-1.98M | 93.18% | -21.15% | -10.79% |
| 2020 | $29.39M | $13.30M | 99.42% | 42.25% | 45.25% |
| 2021 | $38.16M | $15.80M | 99.55% | 45.94% | 41.40% |
| 2022 | $6.03M | $-17.10M | 95.45% | -288.93% | -283.79% |
| 2023 | $4.76M | $-40.83M | 96.99% | -879.53% | -858.15% |
| 2024 | $28.49M | $-13.82M | 99.28% | -140.33% | -48.52% |
| 2025 | $52.15M | $31.71M | 94.30% | 21.83% | 60.81% |
Frequently asked questions
What is XOMA Royalty Corporation's revenue?
XOMA Royalty Corporation's trailing twelve-month revenue is $48.55M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is XOMA?
In its most recent fiscal year, XOMA ran a gross margin of 94.30%, an operating margin of 21.83%, and a net margin of 60.81%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does XOMA generate?
XOMA produced $-17.85M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is XOMA's balance sheet healthy?
XOMA holds $82.91M in cash and equivalents against $96.45M in long-term debt, on $103.96M of shareholder equity. That debt is best read against the cash flow the business throws off each year.